STERILE WATER

STERILE WATER was reported 5483 times

STERILE WATER is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LYSOSOMAL STORAGE DISORDER 6 0.3158
1 HEREDITARY ANGIOEDEMA 582 0.0542
2 PANTOEA AGGLOMERANS INFECTION 3 0.0390
3 GLYCOGEN STORAGE DISEASE TYPE II 4 0.0381
4 THYROID STIMULATING IMMUNOGLOBULIN INCREASED 3 0.0375
5 USE OF ACCESSORY RESPIRATORY MUSCLES 14 0.0339
6 DEAFNESS PERMANENT 6 0.0306
7 CATHETER SITE DISCOMFORT 2 0.0250
8 CATHETERISATION VENOUS 2 0.0244
9 HYDROSALPINX 2 0.0217
10 CENTRAL VENOUS CATHETER REMOVAL 8 0.0171
11 CATHETER REMOVAL 6 0.0168
12 IN VITRO FERTILISATION 3 0.0166
13 ENTEROBACTER TEST POSITIVE 4 0.0163
14 CATHETER SITE VESICLES 3 0.0154
15 CATHETER SITE THROMBOSIS 4 0.0146
16 LIP INFECTION 3 0.0142
17 PRODUCT COMPOUNDING QUALITY ISSUE 5 0.0137
18 INFECTIVE GLOSSITIS 2 0.0128
19 VASCULAR ACCESS COMPLICATION 10 0.0123
20 CATHETER SITE IRRITATION 4 0.0120
21 VASCULAR DEVICE OCCLUSION 4 0.0118
22 ALLERGY TO PLANTS 5 0.0109
23 ENDOCRINE OPHTHALMOPATHY 9 0.0104
24 GRANULOCYTE COUNT DECREASED 19 0.0102
25 DEVICE RELATED BACTERAEMIA 3 0.0097
26 INJECTION SITE PLAQUE 2 0.0095
27 PRODUCT RECONSTITUTION QUALITY ISSUE 8 0.0089
28 NEONATAL INFECTION 3 0.0087
29 OVARIAN HYPERSTIMULATION SYNDROME 20 0.0086
30 FACIAL DISCOMFORT 6 0.0085
31 POOR VENOUS ACCESS 85 0.0082
32 INCISION SITE DISCHARGE 2 0.0079
33 CATHETER SITE EXTRAVASATION 3 0.0075
34 CATHETER SITE SWELLING 7 0.0075
35 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 3 0.0074
36 ANHIDROSIS 3 0.0074
37 NAIL OPERATION 3 0.0072
38 PRODUCT CLOSURE ISSUE 4 0.0072
39 PERIARTHRITIS 14 0.0061
40 CATHETER SITE BRUISE 2 0.0060
41 CENTRAL VENOUS CATHETERISATION 18 0.0060
42 VASCULAR DEVICE INFECTION 27 0.0059
43 URINARY TRACT PAIN 3 0.0059
44 LIGAMENT OPERATION 2 0.0058
45 CATHETER SITE PRURITUS 5 0.0057
46 LARYNGEAL DISORDER 4 0.0055
47 CATHETER PLACEMENT 10 0.0054
48 VEIN RUPTURE 9 0.0054
49 HUMAN RHINOVIRUS TEST POSITIVE 2 0.0054
50 ASYMPTOMATIC COVID-19 2 0.0051
51 CATHETER SITE PAIN 13 0.0050
52 MEDICAL DEVICE SITE INFECTION 3 0.0048
53 SPINAL CORD INFECTION 3 0.0046
54 LARYNGEAL OEDEMA 28 0.0045
55 INSURANCE ISSUE 69 0.0045
56 ENLARGED UVULA 2 0.0045
57 DEVICE RELATED SEPSIS 9 0.0045
58 BLOOD MAGNESIUM INCREASED 4 0.0044
59 ALLERGY TO ARTHROPOD STING 2 0.0044
60 ADMINISTRATION SITE PAIN 5 0.0043
61 INFUSION SITE HAEMATOMA 2 0.0042
62 PRODUCT CONTAMINATION MICROBIAL 5 0.0042
63 TRACHEITIS 3 0.0039
64 FEMALE STERILISATION 2 0.0039
65 INFUSION SITE DISCOMFORT 4 0.0039
66 INFUSION SITE EXTRAVASATION 24 0.0039
67 PRODUCT PREPARATION ISSUE 25 0.0038
68 CROUP INFECTIOUS 3 0.0038
69 INFUSION SITE VESICLES 2 0.0038
70 PRESCRIBED OVERDOSE 72 0.0037
71 MYELOSUPPRESSION 134 0.0037
72 MANUFACTURING PRODUCT SHIPPING ISSUE 2 0.0037
73 PRODUCT SELECTION ERROR 4 0.0036
74 HAND-FOOT-AND-MOUTH DISEASE 3 0.0036
75 BUNION OPERATION 2 0.0036
76 MAST CELL ACTIVATION SYNDROME 5 0.0036
77 MOTOR DEVELOPMENTAL DELAY 2 0.0035
78 CATHETER SITE INFECTION 13 0.0034
79 INCORRECT PRODUCT FORMULATION ADMINISTERED 3 0.0034
80 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 3 0.0034
81 DEAFNESS NEUROSENSORY 11 0.0033
82 INFUSION SITE SWELLING 21 0.0033
83 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 18 0.0033
84 CERUMEN IMPACTION 3 0.0033
85 HAEMATOLOGICAL INFECTION 8 0.0033
86 PSYCHOGENIC SEIZURE 3 0.0032
87 DEVICE RELATED INFECTION 48 0.0031
88 OVARIAN CYST RUPTURED 4 0.0031
89 SPINAL LAMINECTOMY 3 0.0031
90 DEVICE RELATED THROMBOSIS 3 0.0030
91 INFUSION SITE HAEMORRHAGE 10 0.0030
92 DELIVERY 2 0.0030
93 INFUSION SITE INFECTION 7 0.0030
94 SIALOADENITIS 4 0.0029
95 INFUSION SITE RASH 4 0.0029
96 CYSTIC FIBROSIS 16 0.0029
97 INFUSION SITE PAIN 37 0.0029
98 POOR QUALITY PRODUCT ADMINISTERED 30 0.0028
99 IDIOPATHIC URTICARIA 3 0.0028
100 NOROVIRUS INFECTION 4 0.0028
101 POST PROCEDURAL SWELLING 3 0.0027
102 PHARYNGITIS STREPTOCOCCAL 29 0.0027
103 CARDIAC INFECTION 2 0.0027
104 BLOODY DISCHARGE 3 0.0026
105 PRURITUS ALLERGIC 3 0.0026
106 PRODUCT CONTAMINATION 9 0.0025
107 MAMMOPLASTY 2 0.0025
108 RENAL TRANSPLANT 9 0.0025
109 PRODUCT PACKAGING CONFUSION 6 0.0025
110 DERMATITIS CONTACT 28 0.0025
111 INFUSION SITE WARMTH 3 0.0024
112 DYSCHROMATOPSIA 2 0.0024
113 ALLERGY TO CHEMICALS 3 0.0024
114 INFUSION SITE OEDEMA 2 0.0024
115 INFECTED BITE 2 0.0024
116 INCORRECT DRUG ADMINISTRATION RATE 10 0.0023
117 INFUSION SITE IRRITATION 3 0.0023
118 CATHETER SITE ERYTHEMA 5 0.0023
119 EXOPHTHALMOS 5 0.0023
120 WEIGHT FLUCTUATION 24 0.0023
121 INFUSION SITE DISCHARGE 4 0.0023
122 WISDOM TEETH REMOVAL 3 0.0023
123 INFUSION SITE DISCOLOURATION 2 0.0023
124 SINUS PAIN 5 0.0021
125 APPENDIX DISORDER 3 0.0021
126 SKIN ABRASION 10 0.0021
127 WEIGHT ABNORMAL 5 0.0021
128 MULTIPLE ALLERGIES 16 0.0020
129 DEVICE INFUSION ISSUE 5 0.0020
130 INFUSION SITE ERYTHEMA 17 0.0020
131 INFUSION SITE REACTION 6 0.0020
132 GASTROENTERITIS VIRAL 36 0.0020
133 PRODUCT CONTAMINATION PHYSICAL 5 0.0020
134 PRODUCT DEPOSIT 3 0.0019
135 INFUSION SITE PRURITUS 6 0.0019
136 PHARYNGEAL PARAESTHESIA 3 0.0019
137 ANIMAL BITE 5 0.0019
138 INFUSION SITE MASS 2 0.0018
139 PRODUCT DISTRIBUTION ISSUE 17 0.0018
140 COLONOSCOPY 4 0.0018
141 ARTHROPOD STING 3 0.0018
142 VEIN DISORDER 9 0.0018
143 HAEMOGLOBINURIA 2 0.0018
144 CATHETER SITE DISCHARGE 2 0.0018
145 EXPOSURE TO SARS-COV-2 3 0.0018
146 LIGAMENT INJURY 2 0.0018
147 OXYGEN SATURATION ABNORMAL 5 0.0018
148 BLOOD FIBRINOGEN DECREASED 2 0.0018
149 TREATMENT DELAYED 3 0.0017
150 FEBRILE INFECTION 2 0.0017
151 SEASONAL ALLERGY 24 0.0017
152 JUGULAR VEIN THROMBOSIS 3 0.0017
153 DENTAL CARE 3 0.0016
154 PARANASAL SINUS DISCOMFORT 6 0.0016
155 GINGIVAL RECESSION 3 0.0016
156 EAR INFECTION 41 0.0015
157 IMPLANTABLE DEFIBRILLATOR INSERTION 2 0.0015
158 EXPOSURE VIA BREAST MILK 6 0.0015
159 RESPIRATORY TRACT INFECTION 39 0.0015
160 PHARYNGEAL OEDEMA 23 0.0015
161 MATERNAL EXPOSURE DURING BREAST FEEDING 6 0.0015
162 CARBON DIOXIDE INCREASED 2 0.0015
163 MENINGITIS VIRAL 2 0.0015
164 CORNEAL ABRASION 2 0.0015
165 GASTROINTESTINAL INFECTION 13 0.0014
166 CHEST INJURY 3 0.0014
167 STREPTOCOCCAL INFECTION 8 0.0014
168 EYE CONTUSION 3 0.0014
169 PRODUCT PREPARATION ERROR 29 0.0014
170 AUDITORY DISORDER 2 0.0014
171 MENINGITIS BACTERIAL 2 0.0014
172 POOR QUALITY DRUG ADMINISTERED 9 0.0014
173 INFUSION SITE BRUISING 3 0.0014
174 DRUG SPECIFIC ANTIBODY PRESENT 9 0.0014
175 FAT TISSUE INCREASED 2 0.0014
176 ACUTE ABDOMEN 2 0.0014
177 SARS-COV-2 TEST POSITIVE 18 0.0014
178 IMPETIGO 2 0.0013
179 INFECTIOUS MONONUCLEOSIS 3 0.0013
180 SINUSITIS 137 0.0013
181 PRODUCT LABEL ISSUE 9 0.0013
182 EMERGENCY CARE 4 0.0013
183 LIGAMENT SPRAIN 13 0.0013
184 COMPLICATION ASSOCIATED WITH DEVICE 19 0.0013
185 INFERTILITY FEMALE 2 0.0013
186 RHINOVIRUS INFECTION 5 0.0013
187 ORAL SURGERY 3 0.0013
188 BACTERIAL VAGINOSIS 2 0.0013
189 FUNGAEMIA 2 0.0013
190 HAND FRACTURE 9 0.0013
191 INGROWING NAIL 3 0.0013
192 PRODUCT LEAKAGE 7 0.0012
193 DRUG EFFECT INCOMPLETE 45 0.0012
194 WRONG DRUG ADMINISTERED 11 0.0012
195 COSTOCHONDRITIS 2 0.0012
196 DERMAL CYST 3 0.0012
197 CATHETER SITE HAEMORRHAGE 3 0.0012
198 RESPIRATORY TRACT CONGESTION 19 0.0012
199 SINUS CONGESTION 16 0.0012
200 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 210 0.0012
201 MILIARIA 2 0.0012
202 MUSCLE STRAIN 10 0.0012
203 HERNIA REPAIR 3 0.0012
204 TENDERNESS 12 0.0012
205 URINE OUTPUT INCREASED 3 0.0011
206 LUNG TRANSPLANT 4 0.0011
207 CARDIAC ABLATION 2 0.0011
208 POST PROCEDURAL INFECTION 9 0.0011
209 PRODUCT AVAILABILITY ISSUE 25 0.0011
210 BACTERAEMIA 13 0.0011
211 ESSENTIAL HYPERTENSION 2 0.0011
212 UPPER-AIRWAY COUGH SYNDROME 9 0.0011
213 RED BLOOD CELL COUNT INCREASED 3 0.0011
214 CEREBROSPINAL FLUID LEAKAGE 2 0.0011
215 LOCALISED OEDEMA 5 0.0011
216 ARTHRITIS INFECTIVE 5 0.0011
217 EAR DISCOMFORT 11 0.0011
218 ENDOTRACHEAL INTUBATION 3 0.0011
219 EYE INFECTION 12 0.0011
220 NEUTROPHIL COUNT DECREASED 43 0.0011
221 PRODUCT CONTAINER ISSUE 9 0.0010
222 CLAVICLE FRACTURE 4 0.0010
223 WRONG PRODUCT ADMINISTERED 7 0.0010
224 WEIGHT INCREASED 232 0.0010
225 DYSPNOEA AT REST 3 0.0010
226 DYSPNOEA EXERTIONAL 39 0.0010
227 SKIN WARM 6 0.0010
228 DEVICE POWER SOURCE ISSUE 3 0.0010
229 UPPER RESPIRATORY TRACT INFECTION 47 0.0010
230 OBSTRUCTION 4 0.0010
231 INFUSION RELATED REACTION 66 0.0010
232 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 17 0.0010
233 TENSION 6 0.0010
234 SKIN INFECTION 11 0.0010
235 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 33 0.0010
236 ENDOCARDITIS 5 0.0010
237 PRODUCT COLOUR ISSUE 5 0.0010
238 DIASTOLIC DYSFUNCTION 3 0.0010
239 LIQUID PRODUCT PHYSICAL ISSUE 7 0.0010
240 TONSILLITIS 5 0.0010
241 ILLNESS 98 0.0010
242 HYSTERECTOMY 8 0.0009
243 DRUG DISPENSING ERROR 14 0.0009
244 PULMONARY FUNCTION TEST DECREASED 4 0.0009
245 FOOD ALLERGY 7 0.0009
246 MIDDLE EAR EFFUSION 2 0.0009
247 ACCIDENT AT WORK 2 0.0009
248 PHYSICAL DISABILITY 4 0.0009
249 BACTERIAL TEST POSITIVE 2 0.0009
250 LARGE INTESTINAL OBSTRUCTION 2 0.0009
251 CANDIDA INFECTION 15 0.0009
252 DRUG EFFECT DELAYED 4 0.0009
253 ONYCHOCLASIS 6 0.0009
254 VIRAL INFECTION 29 0.0009
255 EYELID DISORDER 2 0.0009
256 NEURALGIA 21 0.0009
257 BACTERIAL INFECTION 16 0.0009
258 DISCOURAGEMENT 2 0.0009
259 TIBIA FRACTURE 4 0.0009
260 FIBRIN D DIMER INCREASED 3 0.0008
261 VIRAL UPPER RESPIRATORY TRACT INFECTION 4 0.0008
262 PROTHROMBIN TIME PROLONGED 5 0.0008
263 WRIST FRACTURE 10 0.0008
264 COVID-19 145 0.0008
265 PRODUCT DOSE OMISSION ISSUE 241 0.0008
266 STAPHYLOCOCCAL INFECTION 27 0.0008
267 KIDNEY INFECTION 16 0.0008
268 BREATH SOUNDS ABNORMAL 4 0.0008
269 LIMB INJURY 22 0.0008
270 ARTHROPOD BITE 6 0.0008
271 RESPIRATORY SYNCYTIAL VIRUS INFECTION 7 0.0008
272 NASOPHARYNGITIS 148 0.0008
273 HYPERNATRAEMIA 4 0.0008
274 APPENDICITIS PERFORATED 2 0.0008
275 PARANASAL SINUS HYPERSECRETION 3 0.0008
276 GASTRIC INFECTION 3 0.0008
277 BODY TEMPERATURE INCREASED 16 0.0008
278 OESOPHAGEAL DISORDER 3 0.0008
279 CONCUSSION 6 0.0008
280 OROPHARYNGEAL DISCOMFORT 7 0.0008
281 WEIGHT DECREASED 216 0.0008
282 EAR PAIN 15 0.0008
283 INFLUENZA 85 0.0008
284 SCAR 13 0.0008
285 FURUNCLE 6 0.0008
286 PNEUMOTHORAX 12 0.0008
287 NO ADVERSE EVENT 136 0.0007
288 HYPERLACTACIDAEMIA 2 0.0007
289 FUNGAL SKIN INFECTION 3 0.0007
290 PRODUCT DOSE OMISSION IN ERROR 21 0.0007
291 BLOOD SODIUM INCREASED 2 0.0007
292 FOOT FRACTURE 14 0.0007
293 LIP BLISTER 2 0.0007
294 CLUMSINESS 2 0.0007
295 SPINAL OPERATION 9 0.0007
296 ANAPHYLACTOID REACTION 3 0.0007
297 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
298 DIZZINESS POSTURAL 7 0.0007
299 HEART RATE ABNORMAL 4 0.0007
300 BRAIN OEDEMA 9 0.0007
301 HYPERPYREXIA 3 0.0007
302 GRANULOCYTOPENIA 4 0.0007
303 JOINT INJURY 15 0.0007
304 SHOULDER OPERATION 3 0.0007
305 PRODUCT SUPPLY ISSUE 5 0.0007
306 CHILLS 82 0.0007
307 LIP PAIN 2 0.0007
308 FIBULA FRACTURE 2 0.0007
309 HORDEOLUM 3 0.0007
310 PRODUCTIVE COUGH 33 0.0007
311 PRODUCT LABEL CONFUSION 4 0.0007
312 CATHETERISATION CARDIAC 3 0.0007
313 SINUS HEADACHE 4 0.0007
314 ATYPICAL PNEUMONIA 2 0.0007
315 BLOOD CULTURE POSITIVE 2 0.0007
316 THROAT TIGHTNESS 18 0.0007
317 SCRATCH 7 0.0007
318 FUNGAL INFECTION 22 0.0007
319 CYSTITIS 21 0.0007
320 ABDOMINAL HERNIA 3 0.0007
321 SINUS DISORDER 13 0.0007
322 LUMBAR VERTEBRAL FRACTURE 3 0.0007
323 ANAPHYLACTIC REACTION 36 0.0007
324 PHARYNGITIS 8 0.0006
325 SKIN LACERATION 7 0.0006
326 BRAIN FOG 10 0.0006
327 EOSINOPHILIC PNEUMONIA 2 0.0006
328 CHEST DISCOMFORT 65 0.0006
329 DIALYSIS 9 0.0006
330 BREAST CANCER RECURRENT 2 0.0006
331 IRIDOCYCLITIS 2 0.0006
332 PRODUCT PACKAGING ISSUE 6 0.0006
333 NASAL CONGESTION 37 0.0006
334 LOSS OF THERAPEUTIC RESPONSE 2 0.0006
335 LIMB OPERATION 3 0.0006
336 EXPOSURE TO TOXIC AGENT 2 0.0006
337 MYASTHENIA GRAVIS 5 0.0006
338 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 44 0.0006
339 WHITE BLOOD CELL COUNT DECREASED 66 0.0006
340 ESCHERICHIA INFECTION 5 0.0006
341 OSTEOMYELITIS 11 0.0006
342 WHEEZING 36 0.0006
343 HYPERVOLAEMIA 3 0.0006
344 CORONAVIRUS INFECTION 4 0.0006
345 ANEURYSM 3 0.0006
346 PROTEIN URINE PRESENT 3 0.0006
347 LYME DISEASE 2 0.0006
348 PREGNANCY 12 0.0006
349 POSTOPERATIVE WOUND INFECTION 4 0.0006
350 BRONCHITIS 43 0.0006
351 LOCALISED INFECTION 14 0.0006
352 PARTIAL SEIZURES 3 0.0006
353 POST PROCEDURAL COMPLICATION 11 0.0006
354 MASS 8 0.0006
355 URINE OUTPUT DECREASED 5 0.0006
356 PRODUCT USE COMPLAINT 9 0.0006
357 BURNING SENSATION 40 0.0006
358 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
359 DEVICE OCCLUSION 8 0.0006
360 PAPULE 4 0.0006
361 THERMAL BURN 4 0.0006
362 RETCHING 12 0.0006
363 TOOTH EXTRACTION 7 0.0006
364 INTENTIONAL DOSE OMISSION 16 0.0006
365 APPENDICECTOMY 2 0.0006
366 FOOD POISONING 3 0.0006
367 IMPAIRED QUALITY OF LIFE 8 0.0006
368 ANAL INCONTINENCE 5 0.0006
369 HEART RATE INCREASED 55 0.0006
370 HIP SURGERY 3 0.0006
371 HOSPITALISATION 85 0.0006
372 PRODUCT PRESCRIBING ISSUE 12 0.0006
373 PULMONARY THROMBOSIS 6 0.0005
374 ROAD TRAFFIC ACCIDENT 23 0.0005
375 PRODUCT USE ISSUE 103 0.0005
376 EXPOSURE DURING PREGNANCY 34 0.0005
377 THROMBOSIS 44 0.0005
378 GASTROINTESTINAL PAIN 6 0.0005
379 TOOTH FRACTURE 6 0.0005
380 CONTUSION 52 0.0005
381 FEELING COLD 15 0.0005
382 CARDIAC DYSFUNCTION 2 0.0005
383 APPENDICITIS 5 0.0005
384 PYREXIA 184 0.0005
385 PERIORBITAL SWELLING 3 0.0005
386 PAIN IN JAW 15 0.0005
387 EXERCISE TOLERANCE DECREASED 3 0.0005
388 TACHYPNOEA 7 0.0005
389 GASTROINTESTINAL DISORDER 46 0.0005
390 THERAPY CHANGE 5 0.0005
391 COUGH 142 0.0005
392 BLOOD IRON DECREASED 6 0.0005
393 MATERNAL EXPOSURE DURING PREGNANCY 45 0.0005
394 CARDIAC PACEMAKER INSERTION 3 0.0005
395 MIGRAINE 48 0.0005
396 SWELLING 47 0.0005
397 SYMPTOM RECURRENCE 3 0.0005
398 DIPLOPIA 13 0.0005
399 FOREIGN BODY 2 0.0005
400 CYSTITIS HAEMORRHAGIC 2 0.0005
401 RHINITIS 4 0.0005
402 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 27 0.0005
403 TOOTH ABSCESS 5 0.0005
404 INFECTION 71 0.0005
405 ABDOMINAL DISTENSION 51 0.0005
406 URINARY TRACT INFECTION 83 0.0005
407 TEMPERATURE INTOLERANCE 5 0.0005
408 NEPHROLITHIASIS 22 0.0005
409 TRANSFUSION 5 0.0005
410 BLEPHAROSPASM 3 0.0005
411 RESPIRATORY DISORDER 14 0.0005
412 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
413 OROPHARYNGEAL PAIN 43 0.0005
414 SKIN SWELLING 4 0.0005
415 NAIL DISORDER 4 0.0005
416 TOOTH INFECTION 6 0.0005
417 PRODUCT FORMULATION ISSUE 3 0.0005
418 COLD SWEAT 8 0.0005
419 LIGAMENT RUPTURE 2 0.0005
420 BLOOD PRESSURE ABNORMAL 9 0.0005
421 ADVERSE REACTION 6 0.0005
422 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
423 RHINORRHOEA 29 0.0004
424 IMPLANT SITE PAIN 2 0.0004
425 FULL BLOOD COUNT DECREASED 9 0.0004
426 SNEEZING 10 0.0004
427 ABNORMAL LOSS OF WEIGHT 3 0.0004
428 HAEMOGLOBIN INCREASED 2 0.0004
429 BLOOD THYROID STIMULATING HORMONE INCREASED 4 0.0004
430 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
431 DIVERTICULITIS 12 0.0004
432 AGRANULOCYTOSIS 8 0.0004
433 SPLENOMEGALY 5 0.0004
434 DRUG LEVEL INCREASED 7 0.0004
435 ENDOMETRIOSIS 2 0.0004
436 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
437 VISUAL FIELD DEFECT 3 0.0004
438 TINNITUS 19 0.0004
439 HEAD INJURY 13 0.0004
440 HORMONE LEVEL ABNORMAL 2 0.0004
441 DISCOMFORT 25 0.0004
442 PHARYNGEAL SWELLING 4 0.0004
443 HEPATOMEGALY 4 0.0004
444 SENSITIVE SKIN 3 0.0004
445 PALLOR 11 0.0004
446 MUCOUS STOOLS 2 0.0004
447 INABILITY TO AFFORD MEDICATION 4 0.0004
448 INJECTION SITE INFLAMMATION 2 0.0004
449 DEVICE ISSUE 36 0.0004
450 THROAT IRRITATION 18 0.0004
451 HYDRONEPHROSIS 3 0.0004
452 HYPOTONIA 4 0.0004
453 BLOOD PRESSURE INCREASED 61 0.0004
454 LACRIMATION INCREASED 12 0.0004
455 HEAD DISCOMFORT 7 0.0004
456 PNEUMONIA 128 0.0004
457 DYSLIPIDAEMIA 2 0.0004
458 DEVICE PHYSICAL PROPERTY ISSUE 3 0.0004
459 SWOLLEN TONGUE 12 0.0004
460 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
461 ORAL CANDIDIASIS 5 0.0004
462 PULMONARY CONGESTION 5 0.0004
463 FALL 126 0.0004
464 CONJUNCTIVITIS 7 0.0004
465 ULCER 6 0.0004
466 SCIATICA 6 0.0004
467 PRODUCT USE IN UNAPPROVED INDICATION 93 0.0004
468 HEPATIC FUNCTION ABNORMAL 14 0.0004
469 EYE HAEMORRHAGE 5 0.0004
470 FRUSTRATION TOLERANCE DECREASED 3 0.0004
471 BLOOD POTASSIUM INCREASED 6 0.0004
472 ERYTHEMA OF EYELID 2 0.0004
473 BACK INJURY 4 0.0004
474 ABNORMAL FAECES 3 0.0004
475 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
476 BLOOD POTASSIUM DECREASED 11 0.0004
477 HERNIA 7 0.0004
478 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
479 INTRACRANIAL PRESSURE INCREASED 2 0.0004
480 HEADACHE 225 0.0004
481 BLOOD UREA INCREASED 6 0.0004
482 ANGIOPATHY 2 0.0004
483 CHEST PAIN 66 0.0004
484 OCULAR DISCOMFORT 4 0.0004
485 SENSATION OF FOREIGN BODY 3 0.0004
486 RASH ERYTHEMATOUS 17 0.0004
487 LIMB DISCOMFORT 11 0.0004
488 VOMITING 167 0.0004
489 HEART RATE IRREGULAR 8 0.0004
490 UPPER LIMB FRACTURE 7 0.0004
491 PSEUDOMONAS INFECTION 3 0.0003
492 SEPSIS 39 0.0003
493 ANAPHYLACTIC SHOCK 9 0.0003
494 HYPOACUSIS 15 0.0003
495 BLOOD PRESSURE DECREASED 23 0.0003
496 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
497 VERTIGO 21 0.0003
498 METABOLIC DISORDER 2 0.0003
499 ELECTROLYTE IMBALANCE 4 0.0003
500 HYPERTRIGLYCERIDAEMIA 2 0.0003
501 GROIN PAIN 3 0.0003
502 PRODUCT COMMUNICATION ISSUE 3 0.0003
503 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
504 CELLULITIS 17 0.0003
505 ACCIDENT 4 0.0003
506 KNEE ARTHROPLASTY 7 0.0003
507 OEDEMA 18 0.0003
508 HYPOAESTHESIA ORAL 5 0.0003
509 EXPIRED PRODUCT ADMINISTERED 11 0.0003
510 INGUINAL HERNIA 2 0.0003
511 EATING DISORDER 7 0.0003
512 PLATELET COUNT DECREASED 35 0.0003
513 MUSCLE SPASMS 60 0.0003
514 CYTOPENIA 4 0.0003
515 HIP ARTHROPLASTY 5 0.0003
516 FEELING HOT 20 0.0003
517 DYSURIA 12 0.0003
518 MENISCUS INJURY 2 0.0003
519 SKIN CANCER 7 0.0003
520 NERVE COMPRESSION 3 0.0003
521 PROCEDURAL PAIN 9 0.0003
522 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
523 HAEMOPTYSIS 9 0.0003
524 ABDOMINAL PAIN 75 0.0003
525 HAEMATURIA 11 0.0003
526 FLANK PAIN 3 0.0003
527 LEUKOPENIA 16 0.0003
528 SECRETION DISCHARGE 4 0.0003
529 DERMATITIS ALLERGIC 4 0.0003
530 INJECTION SITE IRRITATION 4 0.0003
531 PAIN 193 0.0003
532 HYPERSOMNIA 9 0.0003
533 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
534 HERPES ZOSTER 18 0.0003
535 UNRESPONSIVE TO STIMULI 8 0.0003
536 CARDIAC FLUTTER 2 0.0003
537 INCOHERENT 2 0.0003
538 HIATUS HERNIA 4 0.0003
539 SURGERY 18 0.0003
540 VITREOUS FLOATERS 3 0.0003
541 KNEE OPERATION 3 0.0003
542 BODY TEMPERATURE DECREASED 3 0.0003
543 ASPERGILLUS INFECTION 2 0.0003
544 PERICARDIAL EFFUSION 7 0.0003
545 CONDITION AGGRAVATED 92 0.0003
546 OVARIAN CYST 3 0.0003
547 MENTAL DISORDER 13 0.0003
548 MALIGNANT MELANOMA 4 0.0003
549 QUALITY OF LIFE DECREASED 4 0.0003
550 BREAST MASS 2 0.0003
551 HYPERTENSION 63 0.0003
552 FATIGUE 231 0.0003
553 HYPERSENSITIVITY 55 0.0003
554 FEEDING DISORDER 6 0.0003
555 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 5 0.0003
556 SLUGGISHNESS 3 0.0003
557 THERAPY INTERRUPTED 21 0.0003
558 GINGIVAL BLEEDING 4 0.0003
559 BLOOD TESTOSTERONE DECREASED 2 0.0003
560 EYE MOVEMENT DISORDER 2 0.0003
561 ERYTHEMA 60 0.0003
562 UNEVALUABLE EVENT 22 0.0003
563 ENCEPHALITIS 2 0.0003
564 EYE DISCHARGE 3 0.0003
565 PULMONARY HYPERTENSION 6 0.0003
566 MEDICATION ERROR 16 0.0003
567 FORMICATION 2 0.0003
568 EXTRASYSTOLES 2 0.0003
569 PRODUCT ODOUR ABNORMAL 3 0.0003
570 CARPAL TUNNEL SYNDROME 4 0.0003
571 INJECTION SITE URTICARIA 7 0.0003
572 INJECTION SITE DISCOMFORT 3 0.0003
573 OXYGEN SATURATION DECREASED 16 0.0003
574 JOINT DISLOCATION 3 0.0003
575 RENAL PAIN 3 0.0003
576 SINUS TACHYCARDIA 4 0.0003
577 PAIN IN EXTREMITY 83 0.0003
578 LOSS OF CONSCIOUSNESS 36 0.0003
579 URTICARIA 47 0.0003
580 NAUSEA 221 0.0003
581 RENAL DISORDER 13 0.0003
582 PARAESTHESIA ORAL 4 0.0003
583 SEIZURE 32 0.0003
584 INCORRECT DOSE ADMINISTERED 63 0.0003
585 FAECES SOFT 2 0.0003
586 RESTLESS LEGS SYNDROME 5 0.0003
587 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
588 ASPIRATION 3 0.0003
589 DYSPNOEA 155 0.0003
590 MAJOR DEPRESSION 2 0.0003
591 PRODUCT QUALITY ISSUE 37 0.0003
592 BACK PAIN 63 0.0003
593 SYNCOPE 27 0.0003
594 EPISTAXIS 20 0.0003
595 CARDIAC DISORDER 25 0.0003
596 EYE PAIN 15 0.0003
597 DYSARTHRIA 10 0.0003
598 FLUSHING 27 0.0003
599 BLOOD SODIUM DECREASED 5 0.0003
600 PALPITATIONS 31 0.0003
601 SCAB 3 0.0003
602 MICTURITION URGENCY 3 0.0003
603 INTERNAL HAEMORRHAGE 3 0.0003
604 BOWEL MOVEMENT IRREGULARITY 2 0.0003
605 NEOPLASM 3 0.0003
606 LETHARGY 15 0.0003
607 DIZZINESS 130 0.0003
608 ACUTE RESPIRATORY FAILURE 5 0.0003
609 HAEMOLYSIS 2 0.0003
610 LUNG INFECTION 4 0.0003
611 RASH MACULAR 9 0.0003
612 HEART RATE DECREASED 9 0.0003
613 ORAL HERPES 5 0.0003
614 SKIN LESION 7 0.0003
615 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
616 AFFECTIVE DISORDER 2 0.0003
617 CYANOSIS 4 0.0003
618 INJECTION SITE PAIN 78 0.0003
619 COVID-19 PNEUMONIA 3 0.0003
620 NEUROPATHY PERIPHERAL 24 0.0003
621 WOUND 7 0.0003
622 ABDOMINAL DISCOMFORT 42 0.0003
623 HEPATIC ENZYME INCREASED 17 0.0002
624 PRODUCT PHYSICAL ISSUE 5 0.0002
625 TREMOR 41 0.0002
626 MUSCLE TIGHTNESS 4 0.0002
627 PRESYNCOPE 6 0.0002
628 PERIPHERAL SWELLING 38 0.0002
629 TASTE DISORDER 5 0.0002
630 COLITIS ULCERATIVE 11 0.0002
631 BONE MARROW FAILURE 5 0.0002
632 BACK DISORDER 4 0.0002
633 DECUBITUS ULCER 2 0.0002
634 LUNG DISORDER 12 0.0002
635 LIVER INJURY 6 0.0002
636 MALAISE 107 0.0002
637 PHOTOSENSITIVITY REACTION 4 0.0002
638 LOWER RESPIRATORY TRACT INFECTION 11 0.0002
639 ARTHRITIS 19 0.0002
640 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
641 EMBOLISM 2 0.0002
642 NEEDLE ISSUE 7 0.0002
643 PRODUCT STORAGE ERROR 21 0.0002
644 RASH PRURITIC 13 0.0002
645 PRURITUS 92 0.0002
646 INTESTINAL OBSTRUCTION 9 0.0002
647 HAEMODIALYSIS 2 0.0002
648 PERICARDITIS 4 0.0002
649 EYE PRURITUS 8 0.0002
650 ABDOMINAL PAIN UPPER 49 0.0002
651 CARDIAC FAILURE CONGESTIVE 19 0.0002
652 URINARY INCONTINENCE 7 0.0002
653 HEMIPARESIS 4 0.0002
654 ARTHRALGIA 98 0.0002
655 LIVER FUNCTION TEST INCREASED 5 0.0002
656 MUSCULOSKELETAL DISCOMFORT 4 0.0002
657 POOR QUALITY SLEEP 5 0.0002
658 OCULAR HYPERAEMIA 11 0.0002
659 BLOOD MAGNESIUM DECREASED 2 0.0002
660 PLATELET COUNT INCREASED 3 0.0002
661 DEVICE DISLOCATION 10 0.0002
662 MUSCULAR WEAKNESS 26 0.0002
663 BLOOD CALCIUM INCREASED 2 0.0002
664 SLEEP DISORDER 16 0.0002
665 BRADYCARDIA 12 0.0002
666 ANGIOEDEMA 10 0.0002
667 DEHYDRATION 30 0.0002
668 TOOTH DISORDER 5 0.0002
669 GALLBLADDER DISORDER 4 0.0002
670 FACIAL PAIN 2 0.0002
671 MYALGIA 38 0.0002
672 HAEMARTHROSIS 2 0.0002
673 HEAVY MENSTRUAL BLEEDING 2 0.0002
674 DEVELOPMENTAL DELAY 2 0.0002
675 DRUG TOXICITY 3 0.0002
676 RESPIRATORY FAILURE 16 0.0002
677 EXOSTOSIS 2 0.0002
678 INCREASED TENDENCY TO BRUISE 2 0.0002
679 MUSCLE TWITCHING 5 0.0002
680 FLUID RETENTION 11 0.0002
681 POLLAKIURIA 9 0.0002
682 HUNGER 3 0.0002
683 SWELLING FACE 14 0.0002
684 APHONIA 3 0.0002
685 NECK PAIN 12 0.0002
686 ANXIETY 61 0.0002
687 DIARRHOEA HAEMORRHAGIC 2 0.0002
688 HYPOAESTHESIA 32 0.0002
689 SKIN REACTION 3 0.0002
690 ASTHENIA 80 0.0002
691 PHOTOPHOBIA 4 0.0002
692 VISION BLURRED 29 0.0002
693 COLITIS 8 0.0002
694 DYSPHAGIA 20 0.0002
695 PROTEINURIA 4 0.0002
696 EYE INFLAMMATION 2 0.0002
697 LOWER LIMB FRACTURE 4 0.0002
698 PANCREATITIS 11 0.0002
699 AFFECT LABILITY 2 0.0002
700 GASTROENTERITIS 3 0.0002
701 AUTOIMMUNE DISORDER 2 0.0002
702 HAEMORRHOIDS 4 0.0002
703 CHOKING 4 0.0002
704 HAEMOGLOBIN DECREASED 21 0.0002
705 DIARRHOEA 132 0.0002
706 ASCITES 6 0.0002
707 GASTRIC DISORDER 7 0.0002
708 COELIAC DISEASE 2 0.0002
709 ASTHMA 23 0.0002
710 TACHYCARDIA 18 0.0002
711 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
712 HAEMATOCRIT DECREASED 4 0.0002
713 BLADDER DISORDER 2 0.0002
714 PULMONARY MASS 3 0.0002
715 DRY EYE 10 0.0002
716 PNEUMONIA ASPIRATION 5 0.0002
717 PROSTATE CANCER 16 0.0002
718 JOINT SWELLING 24 0.0002
719 ECONOMIC PROBLEM 3 0.0002
720 PRODUCT ADMINISTRATION ERROR 4 0.0002
721 LYMPHADENOPATHY 7 0.0002
722 HYPOTHERMIA 2 0.0002
723 HAEMATEMESIS 5 0.0002
724 EYELID PTOSIS 2 0.0002
725 DRY THROAT 2 0.0002
726 EUPHORIC MOOD 2 0.0002
727 ATRIAL FIBRILLATION 19 0.0002
728 INITIAL INSOMNIA 2 0.0002
729 INJECTION SITE WARMTH 4 0.0002
730 INJECTION SITE PRURITUS 13 0.0002
731 ANKLE FRACTURE 3 0.0002
732 HYPERBILIRUBINAEMIA 2 0.0002
733 EXPOSURE VIA SKIN CONTACT 5 0.0002
734 CRYING 7 0.0002
735 HYPERGLYCAEMIA 7 0.0002
736 HAEMORRHAGE 20 0.0002
737 GASTRITIS 5 0.0002
738 HYPOTENSION 38 0.0002
739 INCONTINENCE 2 0.0002
740 OEDEMA PERIPHERAL 23 0.0002
741 OBESITY 3 0.0002
742 EYE SWELLING 7 0.0002
743 RASH 82 0.0002
744 FEELING ABNORMAL 45 0.0002
745 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9 0.0002
746 PARAESTHESIA 29 0.0002
747 RESPIRATORY ARREST 5 0.0002
748 RESPIRATORY DISTRESS 5 0.0002
749 ILL-DEFINED DISORDER 11 0.0002
750 FOOT DEFORMITY 2 0.0002
751 GAIT INABILITY 6 0.0002
752 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
753 ADVERSE DRUG REACTION 16 0.0002
754 FISTULA 2 0.0002
755 MITRAL VALVE INCOMPETENCE 2 0.0002
756 FLATULENCE 10 0.0002
757 SKIN IRRITATION 8 0.0002
758 INJECTION SITE REACTION 12 0.0002
759 ADVERSE EVENT 16 0.0002
760 EXTRA DOSE ADMINISTERED 7 0.0002
761 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
762 LOCAL SWELLING 3 0.0002
763 CAESAREAN SECTION 2 0.0002
764 DEVICE USE ISSUE 3 0.0002
765 INJURY 12 0.0002
766 INFLUENZA LIKE ILLNESS 14 0.0002
767 DRUG ERUPTION 3 0.0002
768 BLOOD CREATININE INCREASED 11 0.0002
769 HEPATIC FAILURE 5 0.0002
770 APHASIA 5 0.0002
771 BURSITIS 2 0.0002
772 NEOPLASM MALIGNANT 11 0.0002
773 END STAGE RENAL DISEASE 3 0.0002
774 HYPERHIDROSIS 21 0.0002
775 INJECTION SITE RASH 5 0.0002
776 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
777 CARDIOMEGALY 2 0.0002
778 ARTHROPATHY 9 0.0002
779 ABNORMAL WEIGHT GAIN 2 0.0002
780 GENERALISED OEDEMA 2 0.0002
781 CYST 2 0.0002
782 OFF LABEL USE 141 0.0002
783 NERVOUS SYSTEM DISORDER 5 0.0002
784 INJECTION SITE DISCOLOURATION 2 0.0002
785 MUSCULOSKELETAL STIFFNESS 14 0.0002
786 DRUG-INDUCED LIVER INJURY 5 0.0002
787 GASTRIC ULCER 3 0.0002
788 INJECTION SITE SWELLING 12 0.0002
789 HYPOPHAGIA 4 0.0002
790 EYE IRRITATION 9 0.0002
791 CHOLESTASIS 3 0.0002
792 THERAPY CESSATION 8 0.0002
793 DECREASED APPETITE 36 0.0002
794 DYSTONIA 3 0.0002
795 HAEMATOMA 4 0.0002
796 DYSPHONIA 9 0.0002
797 DEAFNESS 4 0.0002
798 CHOLELITHIASIS 5 0.0002
799 DYSPEPSIA 15 0.0002
800 SKIN DISCOLOURATION 7 0.0002
801 INCORRECT PRODUCT STORAGE 2 0.0002
802 DERMATITIS ATOPIC 8 0.0002
803 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
804 DEPRESSED MOOD 8 0.0002
805 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
806 LIP SWELLING 5 0.0001
807 DRY SKIN 20 0.0001
808 BLOOD GLUCOSE INCREASED 28 0.0001
809 TYPE 2 DIABETES MELLITUS 5 0.0001
810 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
811 ARRHYTHMIA 7 0.0001
812 INJURY ASSOCIATED WITH DEVICE 3 0.0001
813 ANAEMIA 28 0.0001
814 RIB FRACTURE 3 0.0001
815 BLISTER 8 0.0001
816 BLOOD TEST ABNORMAL 2 0.0001
817 SKIN EXFOLIATION 12 0.0001
818 CONSTIPATION 31 0.0001
819 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
820 RED BLOOD CELL COUNT DECREASED 4 0.0001
821 BALANCE DISORDER 12 0.0001
822 PRURITUS GENERALISED 3 0.0001
823 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
824 MEMORY IMPAIRMENT 19 0.0001
825 GENERAL PHYSICAL HEALTH DETERIORATION 16 0.0001
826 ANOSMIA 2 0.0001
827 LIVER FUNCTION TEST ABNORMAL 4 0.0001
828 INJECTION SITE ERYTHEMA 17 0.0001
829 DYSSTASIA 4 0.0001
830 INTENTIONAL PRODUCT USE ISSUE 12 0.0001
831 GASTROOESOPHAGEAL REFLUX DISEASE 11 0.0001
832 INFLAMMATION 7 0.0001
833 PSYCHOTIC DISORDER 4 0.0001
834 CARDIOMYOPATHY 2 0.0001
835 SOMNOLENCE 27 0.0001
836 RASH PAPULAR 3 0.0001
837 ECZEMA 7 0.0001
838 HAEMORRHAGE INTRACRANIAL 2 0.0001
839 MUSCULOSKELETAL PAIN 7 0.0001
840 SPEECH DISORDER 7 0.0001
841 IRRITABILITY 8 0.0001
842 CHROMATURIA 3 0.0001
843 EPILEPSY 4 0.0001
844 LYMPHOMA 2 0.0001
845 EJECTION FRACTION DECREASED 2 0.0001
846 DISORIENTATION 5 0.0001
847 PRODUCT PRESCRIBING ERROR 3 0.0001
848 ABSCESS 2 0.0001
849 MOBILITY DECREASED 9 0.0001
850 METABOLIC ACIDOSIS 4 0.0001
851 HYPONATRAEMIA 7 0.0001
852 MENTAL IMPAIRMENT 3 0.0001
853 BLINDNESS 5 0.0001
854 IMPAIRED HEALING 4 0.0001
855 EYE DISORDER 4 0.0001
856 SKIN DISORDER 4 0.0001
857 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
858 FACE OEDEMA 2 0.0001
859 NEUTROPENIA 16 0.0001
860 CIRCULATORY COLLAPSE 2 0.0001
861 RECTAL HAEMORRHAGE 5 0.0001
862 THROMBOCYTOPENIA 13 0.0001
863 PULMONARY EMBOLISM 11 0.0001
864 EMOTIONAL DISTRESS 14 0.0001
865 THERAPEUTIC RESPONSE DECREASED 7 0.0001
866 VAGINAL HAEMORRHAGE 5 0.0001
867 DEVICE USE ERROR 4 0.0001
868 GAIT DISTURBANCE 22 0.0001
869 SEPTIC SHOCK 5 0.0001
870 JOINT STIFFNESS 3 0.0001
871 HYPOXIA 4 0.0001
872 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
873 LIVER DISORDER 5 0.0001
874 CARDIAC FAILURE 9 0.0001
875 SKIN BURNING SENSATION 8 0.0001
876 PULMONARY OEDEMA 5 0.0001
877 BLOOD BILIRUBIN INCREASED 3 0.0001
878 LEUKOCYTOSIS 2 0.0001
879 PANIC ATTACK 4 0.0001
880 TREATMENT NONCOMPLIANCE 6 0.0001
881 DRUG INEFFECTIVE 143 0.0001
882 INJECTION SITE MASS 4 0.0001
883 HEPATIC STEATOSIS 2 0.0001
884 MIDDLE INSOMNIA 2 0.0001
885 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
886 HYPOCALCAEMIA 2 0.0001
887 FRACTURE 2 0.0001
888 BLOOD URINE PRESENT 2 0.0001
889 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
890 GLAUCOMA 2 0.0001
891 ERUCTATION 2 0.0001
892 BONE PAIN 6 0.0001
893 ACUTE MYOCARDIAL INFARCTION 3 0.0001
894 LABORATORY TEST ABNORMAL 3 0.0001
895 CATARACT 6 0.0001
896 CEREBROVASCULAR ACCIDENT 17 0.0001
897 PREMATURE BABY 3 0.0001
898 STOMATITIS 6 0.0001
899 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 7 0.0001
900 DRUG ADMINISTRATION ERROR 3 0.0001
901 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
902 FEMUR FRACTURE 3 0.0001
903 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
904 CARDIO-RESPIRATORY ARREST 4 0.0001
905 MOUTH ULCERATION 2 0.0001
906 DYSGEUSIA 7 0.0001
907 IRRITABLE BOWEL SYNDROME 2 0.0001
908 NIGHT SWEATS 3 0.0001
909 HOT FLUSH 7 0.0001
910 DISTURBANCE IN ATTENTION 5 0.0001
911 LACTIC ACIDOSIS 3 0.0001
912 DEEP VEIN THROMBOSIS 6 0.0001
913 DEPRESSION 21 0.0001
914 DEVICE LEAKAGE 4 0.0001
915 AMNESIA 6 0.0001
916 DIABETES MELLITUS 7 0.0001
917 VISUAL ACUITY REDUCED 3 0.0001
918 PANCYTOPENIA 5 0.0001
919 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 18 0.0001
920 DEATH 75 0.0001
921 HYPERKALAEMIA 3 0.0001
922 CARDIAC ARREST 7 0.0001
923 DISEASE PROGRESSION 10 0.0001
924 BLOOD PRESSURE FLUCTUATION 2 0.0001
925 DRUG INTOLERANCE 8 0.0001
926 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
927 FIBROMYALGIA 2 0.0001
928 PLEURAL EFFUSION 5 0.0001
929 ACCIDENTAL OVERDOSE 3 0.0001
930 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
931 CONFUSIONAL STATE 13 0.0001
932 AGEUSIA 2 0.0001
933 RHEUMATOID ARTHRITIS 9 0.0001
934 CARDIOVASCULAR DISORDER 2 0.0001
935 ERECTILE DYSFUNCTION 2 0.0001
936 NERVOUSNESS 4 0.0001
937 ALOPECIA 15 0.0001
938 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
939 INJECTION SITE BRUISING 6 0.0001
940 FEAR 2 0.0001
941 JAUNDICE 2 0.0001
942 DRUG EFFECT DECREASED 4 0.0001
943 DEVICE BREAKAGE 3 0.0001
944 MOOD ALTERED 2 0.0001
945 OSTEOPOROSIS 3 0.0001
946 MENTAL STATUS CHANGES 2 0.0001
947 DEMENTIA 2 0.0001
948 RENAL IMPAIRMENT 6 0.0001
949 INSOMNIA 19 0.0001
950 DEVICE MALFUNCTION 5 0.0001
951 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
952 ANGINA PECTORIS 2 0.0001
953 AGITATION 5 0.0001
954 RENAL FAILURE 9 0.0001
955 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
956 ACUTE KIDNEY INJURY 10 0.0001
957 HYPOKALAEMIA 3 0.0001
958 COGNITIVE DISORDER 3 0.0001
959 MOOD SWINGS 2 0.0001
960 HYPOTHYROIDISM 2 0.0001
961 INJECTION SITE HAEMORRHAGE 5 0.0001
962 HIP FRACTURE 2 0.0001
963 ANGER 2 0.0001
964 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
965 VISUAL IMPAIRMENT 7 0.0001
966 CEREBRAL HAEMORRHAGE 2 0.0001
967 HAEMATOCHEZIA 3 0.0001
968 MYOCARDIAL INFARCTION 9 0.0001
969 ABNORMAL BEHAVIOUR 2 0.0001
970 DYSKINESIA 2 0.0000
971 INTENTIONAL PRODUCT MISUSE 4 0.0000
972 SUICIDAL IDEATION 4 0.0000
973 BREAST CANCER 4 0.0000
974 COMA 2 0.0000
975 COLORECTAL CANCER 2 0.0000
976 BLOOD GLUCOSE DECREASED 2 0.0000
977 HYPOGLYCAEMIA 2 0.0000
978 UNDERDOSE 3 0.0000
979 HALLUCINATION 3 0.0000
980 ACNE 3 0.0000
981 CHRONIC KIDNEY DISEASE 3 0.0000
982 PSORIASIS 5 0.0000
983 DRY MOUTH 3 0.0000
984 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
985 DRUG DOSE OMISSION 6 0.0000
986 CONVULSION 2 0.0000
987 OVERDOSE 7 0.0000
988 MALIGNANT NEOPLASM PROGRESSION 2 0.0000